CASE STUDY #1: POLARITY
DESCRIPTION OF EXTERNAL RELATIONSHIP
Dr. Mychals has a royalty agreement with NovaGnu based on the sales of their Gnums, an anti-inflammatory agent for gums. Dr. Mychals has submitted an IRB application to investigate. Dr. Mychals' role in the study is the surgical placement of the implants. His contact with patients ends after follow-up, four - five months after surgical placement. Dr. Mychals does not hold an executive position at NovaGnu nor does he serve on the Board of Directors.
Dr. Mychals’ potential conflict arises because he expects to receive more than $10,000 in royalty income. NovaGnu is sponsoring the above-mentioned research, and Dr. Mychals has requested to be the Principal Investigator (PI) of the research performed at the University.
Dr. Mychals attended the CRC meeting and requested to retain his financial interest and be the PI of the above-mentioned research at the University of Minnesota. The Committee agreed to allow him to retain his royalty agreement and be the PI of the research. The Committee considered the following factors when making their decision:
Due to the above safeguards currently in place, as well as those implemented by the following management plan, the Committee felt there was a low risk that Dr. Mychal’s ’s financial interest in NovaGnu would compromise the objectivity of his University research or the safety of the research subjects.
AREAS OF POTENTIAL CONFLICT OF INTEREST
The Committee finds that Dr. Mychals has a financial interest in NovaGnu which represents a potential conflict of interest under the following provision of the Regents Policy:
An employee participating in clinical trials or evaluation or development of a technology, process, or product owned or controlled by a business in which the employee, an immediate family member or an associated entity has a financial or business interest. Regents Policy on Financial or Business Conflict of Interest (July 10, 1998), art. 5, sec.III, subds.1(a), p. 13
CONFLICT MANAGEMENT PLAN
Dr. Mychals will not be involved in patient recruitment or the informed consent process. Those tasks will be performed by a Co-PI without a financial or business interest in NovaGnu.